MIR4684

Across TCGA pan-cancer cohorts, MIR4684 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR4684 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR4684 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4684 expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

KIRC, MESO, and BRCA are the cancer types where MIR4684 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	II,III,IV	0.252	0.766	.001	114	view →
MESO	OS	Tertile	III,IV	0.077	0.580	<.001	90	view →
BRCA	OS	Tertile	All	0.767	0.927	.001	48	view →
OV	DFS	Tertile	IV	0.243	0.480	.030	30	view →
UCS	DFS	Tertile	III,IV	1.000	0.222	.046	12	view →
PRAD	OS	Tertile	All	0.929	0.995	.001	12	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR4684–KIRC (DFS)

Open the KIRC breakdown →